NCT05487235 2025-07-03
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Phase 1 Completed
Genentech, Inc.
Bristol-Myers Squibb
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca